Bayer, Merck, MSD at Nov PBAC

By Megan Brodie 3 years ago | In Companies, Products, Regulatory
  • 3 years ago

28 June 2021 Bayer, Merck and MSD have lined up their cancer therapies for consideration…

This is subscriber-only content. Please login to continue reading.